Analysis of the Myc-induced pancreatic β cell islet tumor microenvironment using imaging ToF-SIMS
Source abstract
Abstract
Solid tumors are a structurally complex system, composed of many different cell types. The tumor microenvironment includes nonmalignant cell types that participate in complex interactions with tumor cells. The cross talk between tumor and normal cells is implicated in regulating cell growth, metastatic potential, and chemotherapeutic drug resistance. A new approach is required to interrogate and quantitatively characterize cell to cell interactions in this complex environment. Here, the authors have applied time-of-flight secondary ion mass spectrometry (ToF-SIMS) to analyze Myc-induced pancreatic β cell islet tumors. The high mass resolution and micron spatial resolution of ToF-SIMS allows detection of metabolic intermediates such as lipids and amino acids. Employing multivariate analysis, specifically, principal component analysis, the authors show that it is possible to chemically distinguish cancerous islets from normal tissue, in addition to intratumor heterogeneity. These heterogeneities can then be imaged and investigated using another modality such as sum harmonic generation microscopy. Using these techniques with a specialized mouse model, the authors found significant metabolic changes occurring within β cell tumors and the surrounding tissues. Specific alterations of the lipid, amino acid, and nucleotide metabolism were observed, demonstrating that ToF-SIMS can be utilized to identify large-scale changes that occur in the tumor microenvironment and could thereby increase the understanding of tumor progression and the tumor microenvironment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanopore and Nanochannel Transport Studies · Mass Spectrometry Techniques and Applications · Ion-surface interactions and analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering, University of Washington 1 , Seattle, Washington 98195
Fred Hutchinson Cancer Research Center 2 , Seattle, Washington 98109
Funding
National Institutes of Health · National Institute of Biomedical Imaging and Bioengineering · National Science Foundation
References (71)
Show source-provided references
1. Oncogene · 2008 · 27 · 590410.1038/onc.2008.271 ↗
2. J. Natl. Cancer Inst. · 2007 · 99 · 144110.1093/jnci/djm135 ↗
3. J. Cell Sci. · 2016 · 129 · 336710.1242/jcs.181016 ↗
4. Cancer Cell · 2006 · 10 · 11310.1016/j.ccr.2006.06.017 ↗
5. Cancer Discov. · 2015 · 5 · 102410.1158/2159-8290.CD-15-0507 ↗
6. Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 1878210.1073/pnas.0810199105 ↗
7. Proc. Natl. Acad. Sci. U.S.A. · 2013 · 110 · 1025810.1073/pnas.1222404110 ↗
8. J. Biol. Chem. · 2014 · 289 · 2538210.1074/jbc.M114.580662 ↗
9. Cold Spring Harb. Perspect. Med. · 2014 · 4 · a01422510.1101/cshperspect.a014225 ↗
10. Mol. Cell Biol. · 2005 · 25 · 622510.1128/MCB.25.14.6225-6234.2005 ↗
11. J. Biol. Chem. · 2010 · 285 · 3626710.1074/jbc.M110.141606 ↗
12. J. Lipid Res. · 2013 · 54 · 33310.1194/jlr.M027961 ↗
13. Biointerphases · 2015 · 11 · 02A30310.1116/1.4929633 ↗
14. Anal. Chem. · 2015 · 87 · 669610.1021/acs.analchem.5b00842 ↗
15. Anal. Chem. · 2010 · 82 · 343010.1021/ac9029482 ↗
16. Anal. Chem. · 2015 · 87 · 6410.1021/ac504543v ↗
17. Anal. Chem. · 2012 · 84 · 890910.1021/ac301853q ↗
18. Anal. Chem. · 2013 · 85 · 1086910.1021/ac402288d ↗
19. Proc. Natl. Acad. Sci. U.S.A. · 2015 · 112 · 653910.1073/pnas.1507228112 ↗
20. Cancer Res. · 2016 · 76 · 460810.1158/0008-5472.CAN-15-3403 ↗
21. Cell · 2002 · 109 · 32110.1016/S0092-8674(02)00738-9 ↗
22. Nucleic Acids Res. · 1995 · 23 · 168610.1093/nar/23.10.1686 ↗
23. Appl. Surf. Sci. · 2006 · 252 · 696610.1016/j.apsusc.2006.02.126 ↗
24. Biointerphases · 2015 · 10 · 01900810.1116/1.4907860 ↗
25. Anal. Chem. · 2007 · 79 · 925310.1021/ac070993k ↗
26. Proc. Natl. Acad. Sci. U.S.A. · 2013 · 110 · 1849610.1073/pnas.1310885110 ↗
27. Fundam. Clin. Pharmacol. · 1992 · 6 · 12310.1111/j.1472-8206.1992.tb00103.x ↗
28. J. Histochem. Cytochem. · 2013 · 61 · 91010.1369/0022155413502792 ↗
29. Nature · 2003 · 422 · 17310.1038/nature01478 ↗
30. Genetics · 2011 · 188 · 46110.1534/genetics.110.125724 ↗
31. Microsc. Microanal. · 2015 · 21 · 206510.1017/S1431927615011101 ↗
32. Nature · 2000 · 407 · 24910.1038/35025220 ↗
33. Am. J. Pathol. · 2000 · 156 · 136310.1016/S0002-9440(10)65006-7 ↗
34. Proc. Natl. Acad. Sci. U.S.A. · 2014 · 111 · 1045010.1073/pnas.1409778111 ↗
35. Sci. Rep. · 2017 · 7 · 1332410.1038/s41598-017-13187-5 ↗
36. Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 707510.1073/pnas.0832308100 ↗
37. PLoS ONE · 2015 · 10 · e013404910.1371/journal.pone.0134049 ↗
38. Science · 2009 · 324 · 102910.1126/science.1160809 ↗
39. Exp. Mol. Med. · 2016 · 48 · e24510.1038/emm.2016.81 ↗
40. PLoS ONE · 2011 · 6 · e2364410.1371/journal.pone.0023644 ↗
41. Proc. Natl. Acad. Sci. U.S.A. · 2013 · 110 · 393710.1073/pnas.1219592110 ↗
42. BMC Genomics · 2011 · 12 · 47610.1186/1471-2164-12-476 ↗
43. Cancer Cell · 2007 · 11 · 29110.1016/j.ccr.2007.01.012 ↗
44. Cancer Cell · 2009 · 16 · 37910.1016/j.ccr.2009.09.027 ↗
45. Cancer Res. · 2006 · 66 · 459110.1158/0008-5472.CAN-05-3826 ↗
46. Nat. Commun. · 2015 · 6 · 887310.1038/ncomms9873 ↗
47. Oncogene · 2009 · 28 · 248510.1038/onc.2009.112 ↗
48. Oncotarget · 2016 · 7 · 3037910.18632/oncotarget.8856 ↗
49. Trends Mol. Med. · 2008 · 14 · 46110.1016/j.molmed.2008.08.005 ↗
50. Prostaglandins Other Lipid Mediat. · 2011 · 96 · 2710.1016/j.prostaglandins.2011.08.004 ↗
51. Anal. Chem. · 2016 · 88 · 1194610.1021/acs.analchem.6b03884 ↗
52. Biochemistry · 2002 · 33 · 1328410.1021/bi00249a015 ↗
53. Mol. Imaging · 2004 · 3 · 31910.1162/1535350042973517 ↗
54. Cold Spring Harb. Perspect. Med. · 2013 · 3 · a01421710.1101/cshperspect.a014217 ↗
55. Trends Biochem. Sci. · 2014 · 39 · 19110.1016/j.tibs.2014.02.004 ↗
56. Trends Cell Biol. · 2017 · 27 · 64510.1016/j.tcb.2017.05.001 ↗
57. Nat. Rev. Cancer · 2016 · 16 · 65010.1038/nrc.2016.81 ↗
58. PLoS ONE · 2011 · 6 · e2588110.1371/journal.pone.0025881 ↗
59. EMBO Rep. · 2017 · 18 · 56910.15252/embr.201643068 ↗
60. Mol. Cell Biol. · 2002 · 22 · 579310.1128/MCB.22.16.5793-5800.2002 ↗
61. Nat. Rev. Cancer · 2013 · 13 · 57210.1038/nrc3557 ↗
62. Cancer Res. · 1998 · 58 · 1444
63. Am. J. Physiol. · 1998 · 275 · G1410.1152/ajpgi.1998.275.1.G14 ↗
64. Nat. Rev. Genet. · 2014 · 15 · 9310.1038/nrg3607 ↗
65. Oncol. Rep. · 2012 · 28 · 86210.3892/or.2012.1878 ↗
66. Clin. Exp. Metastasis · 1990 · 8 · 39310.1007/BF00058152 ↗
67. Psychosom. Med. · 1989 · 51 · 17310.1097/00006842-198903000-00007 ↗
68. J. Nutr. · 2006 · 136 · 237S10.1093/jn/136.1.237S ↗
69. Science · 2013 · 339 · 22210.1126/science.1226603 ↗
70. Cancer Res. · 2010 · 70 · 85910.1158/0008-5472.CAN-09-3556 ↗
71. See supplementary material at https://doi.org/10.1116/1.5038574E-BJIOBN-13-302806 for ToF-SIMS images for individual ions not shown in main text as well as extra PCA results and SHG images.